Rejuvenated T cells attacking tumor cells
and leading them to apoptosis
Cell Stem Cell.
2018 Dec 6;23(6):850-858.e4. doi: 10.1016/
j.stem.2018.10.005. Epub 2018 Nov 15.
Cure each cancer patient,
and remove fears from patients,
cancer survivors and families for good.
iPS cells reprogrammed from T cells
Trained in Immunology, >15 year experience with heading oncology and metabolism researches. Being involved in development of T cell therapeutics for clinical testing at Thyas Co. Ltd.
Associate Professor at Kyoto University. Renowned scientist and authority on T cell differentiation from iPS cells. Familiar to Japanese regulations on cell therapy and regenerative therapy products
Ryosuke Gonotsubo has an LL.B. from Kyoto University and an MBA from the Tepper School of Business, Carnegie Mellon University. He joined Kyoto University Innovation Capital in September 2015 and his current duties encompass life science (iPSC), energy, IoT, and AI. He is also a Director of Stem Cell and Device Laboratory, Inc.; and Space Power Technologies Inc.
He was formerly the manager of Business Development and Investment Innovation Office at Kanematsu Corporation, one of the largest Japanese investment and trading conglomerates. While he led domestic and overseas investment, he also initiated the new business creation of an electric vehicle (EV) battery charging network and a smartphone application for EV taxis.
Dr. Hiroyuki Ueno earned his Ph.D. from Osaka University and presently serves as an officer for Kyoto University Innovation Capital. He has invested in life science and healthcare companies and also holds director or observer roles in such firms, including Chordia Therapeutics, Drawbridge Health, AlphaNavi Pharma, Kola-Gen Pharma, and CleanHearing.
His previous positions include work as a Fellow for Sumitomo Dainippon Pharmaceutical Company and Principal Scientist for Takeda Pharmaceutical Company. He is a widely published author in the fields of genetics, molecular biology, physiology, and drug discovery.
Professor emeritus, Kyoto University. He graduated from Department of Physics, Faculty of Science, Kyoto university. After his graduation, he has been fascinated by biological processes especially regulation of immune system, and studying functional diversity of helper T cells and thymic T cell differentiation. His research lead to identification of precursor T cells and critical elements of T cell differentiation. He established Kyoto T Cell Conference (KTCC) in 1991 to accelerate global interaction of T cell researchers. He serves as a scientific advisor in the field of immunology and oncology for Thyas Co.Ltd.